磺丁基醚-β-环糊精修饰毛细管电色谱拆分地平类药物对映体

采用甲基丙烯酸缩水甘油酯原位聚合物基质,将磺丁基醚-β-环糊精修饰到毛细管内壁,制得了一种毛细管电色谱手性柱(SECDP),并通过红外光谱(IR)和扫描电子显微镜(SEM)表征了其结构.磺酸基可提供足够稳定的正向电渗流(EOF),基于磺丁基醚-β-环糊精在固定相和流动相中的协同作用,通过优化手性添加剂浓度、pH值、施加电压、温度及有机调节剂含量等条件,利用该开管电色谱柱拆分了氨氯地平、尼莫地平和尼卡地平等10种地平类手性药物对映体.优化的流动相组成为20 mmol/L NaH2PO4(pH=4.0),含4.0 mmol/L磺丁基醚-β-环糊精,乙腈的体积分数为10%~25%,施加电压15~25 kV,温度为15℃,电动进样2 kV×5 s,检测波长为236 nm.在上述条件下,分离度(RS)可达3.62,柱效达61011块/m,分析时间一般为6~15 min.基于色谱分离数据,探讨了相关的手性分离机理.     

毛细管电泳磺丁基-β-环糊精拆分对映体

将平均取代度为３．８的负电性磺丁基－β－环糊精手性添加剂应用于毛细管电泳对映体拆分的研究中。考察了背景电解质pＨ及磺丁基－β－环糊精浓度对手性拆分的影响,应用磺 丁基－β－环糊精拆分八对碱性酸性的药物对映体。     

β-环糊精毛细管电色谱法拆分和测定马尼地平、尼卡地平对映体

采用溶胶-凝胶法制备对硝基苯氨基甲酸酯化β-环糊精毛细管开管柱(NCDP),建立了分别拆分钙离子阻滞剂盐酸马尼地平和盐酸尼卡地平对映体的毛细管电色谱方法。 采用红外光谱、扫描电子显微镜对其进行了必要的结构及形态表征。 在极性有机模式下,考察了有机溶剂的组成及含量、三乙胺和冰醋酸的含量、运行电压、温度对手性分离的影响。 优化的条件为：温度20℃,检测波长236 nm,压力进样(3.448 kPa×3 s),盐酸马尼地平在乙腈-甲醇-三乙胺-冰醋酸(体积比57∶43∶0.05∶0.07)流动相中,运行电压25 kV时,分离度(RS)为1.39;盐酸尼卡地平在乙腈-甲醇-三乙胺-冰醋酸(体积比55∶45∶0.05∶0.08)流动相中,运行电压20 kV时,分离度为1.30。 上述两种地平对映体保留时间和峰面积的RSD分别小于1.2%和5.6%(n=5),表明所制备的电色谱柱有良好的稳定性。 盐酸马尼地平的拆分时间＜5 min,盐酸尼卡地平的拆分时间＜7 min,有利于建立快速测定其对映体含量的方法。 盐酸马尼地平和盐酸尼卡地平在5.2~125 mg/L范围内线性关系良好(r≥0.9969),检测限分别为1.8和2.3 mg/L(S/N=3)。 初步将NCDP柱用于盐酸马尼地平片和盐酸尼卡地平缓释胶囊中对映体含量的测定。     

毛细管电动色谱带电环糊精拆分N-FMOC氨基酸对映体

 将负电性磺丁基 -β -环糊精手性添加剂应用于毛细管电泳氨基酸对映体的拆分研究中 ,对 8种氨基酸对映体与 9-芴甲基氧基甲酰氯 (FMOC-Cl)生成的衍生物进行了分离 ,其中 5种得到了基线分离。考察了背景电解质 p H值及磺丁基 -β -环糊精的浓度对 N-FMOC氨基酸对映体拆分的影响。     

磺丁基醚-β-环糊精拆分莫达非尼及其立体选择性差异研究

利用毛细管电泳和分子模拟对磺丁基醚-β-环糊精(SBE-β-CD)在莫达非尼手性拆分中的立体选择性差异进行了研究。考察了环糊精浓度和温度对对映体手性拆分的影响。在15~35℃温度范围内,考察了对映体的保留和分离行为。结果表明,随着温度的升高,手性分离变差,并以lnα对1/T作图,得到的Van’t Hoff曲线具有良好线性关系(r=0.995)。热力学结果表明,此手性拆分过程为焓控过程。在5~50 mmol/L范围内,考察了SBE-β-CD浓度对分离的影响,采用双倒数法求得莫达非尼S-和R-对映体与SBE-β-CD的结合常数分别为58.0和70.6 L/mol。分子模拟实验以Gold对接完成,结果表明,莫达非尼R-对映体相比S-对映体与SBE-β-CD结合更稳定,且两对映体与SBE-β-CD结合的差异主要来源与氢键贡献的差异。     

磺丁基醚-β-环糊精手性流动相添加剂法分离兰索拉唑对映体

采用磺丁基醚-β-环糊精(SBE-β-CD)为手性流动相添加剂,建立了兰索拉唑对映体的高效液相色谱分离分析方法.对影响兰索拉唑对映体分离的主要因素:环糊精种类和浓度、缓冲溶液pH以及有机改性剂种类和含量进行考察.确定最优色谱条件:色谱柱为Spherigel C18 (150 mm×4.6 mm,5 μm),流动相为V(乙腈):V(水相)=20:80(水相含10 mmol/L SBE-β-CD、 10 mmol/L NaH2PO4缓冲液、 pH 2.5),流速为0.9 mL/min,检测波长为288 nm.在此条件下,兰索拉唑对映体的保留时间分别为14.4和15.8 min,分离度为2.0.两对映体质量浓度在0.2～50 μg/mL范围内线性关系良好(r≥0.9996),保留时间的RSD分别为0.27%和0.26%,峰面积的RSD分别为0.65%和0.68%.     

磺丁基醚-β-环糊精手性流动相添加剂法拆分佐匹克隆对映体

采用磺丁基醚-β-环糊精(SBE-β-CD)为手性流动相添加剂,建立了反相高效液相色谱手性流动相添加剂法拆分分离佐匹克隆对映体的方法。在普通C18色谱柱(250 mm×4.6 mm×5.0μm)上,考察了水相pH、磺丁基醚-β-环糊精浓度、磷酸盐缓冲液浓度、甲醇含量、柱温等对佐匹克隆对映体拆分效果的影响。确定最适用的色谱条件:流动相为水相(5 mmol/L NaH2PO4,含磺丁基醚-β-环糊精5 mmo/L,以H3PO4调pH为3):甲醇=78:22(V/V),检测波长305nm,流速为1 mL/min,柱温为30℃,此条件下佐匹克隆对映体的保留时间分别为23.0和25.6 min,分离度为1.81。两对对映体质量浓度在0.04~0.36g/L范围内线性关系良好(r≥0.9990),保留时间的RSD分别为0.73%和0.80%,峰面积的RSD分别为1.2%和1.1%。     

羟丙基-β-环糊精对1-羟基芘与牛血清白蛋白相互作用的影响

在模拟生理条件下, 利用荧光光谱、 圆二色光谱和紫外-可见吸收光谱探究了羟丙基-β-环糊精(HPCD)对1-羟基芘(1-OHPyr)与牛血清白蛋白(BSA)相互作用的影响及其相关机制. 结果表明, 291 K下HPCD可使1-OHPyr与BSA的结合常数降低为1.45×10⁵ L/mol; 导致1-OHPyr-BSA体系中BSA的α-螺旋含量恢复, 色氨酸(TRP)残基周围微环境的极性变化减弱; 致使1-OHPyr及BSA的荧光寿命均延长, 且二者的结合距离增大. 初步研究结果表明, HPCD与1-OHPyr的包络作用是HPCD影响BSA与1-OHPyr结合的主要原因.     

两种β-环糊精单臂键合固定相液相色谱法拆分三唑类手性农药

以有序介孔材料SBA-15为基质, β-环糊精和氨基β-环糊精为配体, 通过环糊精端口的羟基和氨基与3-异氰酸丙基三乙氧基硅烷偶联剂上活泼的异氰酸酯基之间的加成反应, 制备了2种不同单键合臂的β-环糊精修饰SBA-15手性固定相(CDSP和NCDSP), 它们分别含有稳定的氨基甲酸酯基和脲基键合臂. 在反相高效液相色谱模式下, 以灭菌唑、 烯唑醇、 己唑醇和戊唑醇等10种常见的三唑类手性农药为探针, 考察了CDSP和NCDSP的基本手性色谱性能. 研究结果表明, 2种新固定相对三唑类农药对映体均有较好的快速拆分能力, 所需分离时间较短(< 30 min), 其中灭菌唑和烯唑醇的选择性因子(α)分别为1.29和1.28, 分离度分别达到3.84和3.23. 采用甲醇、 乙腈和水组成的简单流动相, 室温下在CDSP和NCDSP上分别拆分了9种和8种三唑类手性农药对映体. 研究发现拥有适当大小和手性碳连接羟基的三唑类农药在上述2种新固定相上有较好的拆分效果, 说明固定相上的环糊精配体对溶质的包结、 氢键和空间位阻等协同作用对空间手性识别有重要贡献. 不同批次CDSP和NCDSP的键合量分别为0.139~0.156和0.120~0.137 μmol/m², 表明2种固定相的制备方法有较好的重现性. 与涂覆型纤维素商品柱相比, 新的脲基环糊精固定相性能更稳定, 反相色谱实用性更强, 且制备方法简便, 成本较低, 在三唑类手性农药对映体残留量检测中具有良好的应用前景.     

磺酸化β-环糊精聚合物的合成及其在毛细管电泳手性拆分中的应用

用三氧化硫吡啶复合物将β-环糊精与环氧氯丙烷反应得到的β-环糊精聚合物进行磺酸化,得到磺酸化的β-环糊精聚合物,并对其进行了红外光谱和1H NMR表征。将磺酸化β-环糊精聚合物作为手性添加剂,用于毛细管电泳手性药物拆分中,在区带电泳模式下,对5种药物特布他林、山莨菪碱、奥美拉唑、扑尔敏、氧氟沙星进行拆分,并考察了缓冲溶液pH值、运行电压、手性添加剂浓度、有机溶剂对手性拆分的影响。1H NMR分析结果表明:此聚合物为不均一取代的磺酸化β-环糊精;毛细管电泳结果表明,此聚合物具有良好的拆分效果,在磺酸化β-环糊精聚合物浓度为5 g/L,运行电压15 kV条件下,对特布他林、扑尔敏的分离度达到3.0以上;对于山莨菪碱的两对对映体均可实现良好拆分,分离度达到2.0以上。     

基于β-环糊精的多肽支臂星状聚合物的制备及性能

以β-环糊精(β-CD)为起始原料, 通过磺酰化及乙二胺基取代等过程, 制备具有端氨基的中间体β-环糊精(6-en-β-CD); 再以6-en-β-CD为引发剂, 通过赖氨酸N-羧基环内酸酐(Lys-NCA)和谷氨酸N-羧基环内酸酐(Glu-NCA)的混合开环聚合(ROP)和脱苄氧羰基(Cbz)保护等反应, 制备了以β-CD为核、 混聚多肽为支臂的星状聚合物[6-聚(谷氨酸-赖氨酸)-β-CD]. 以基质辅助激光解吸电离飞行时间质谱(MALDI-TOF-MS)、 核磁共振波谱(NMR)和傅里叶变换红外光谱(FTIR)等对星状聚合物及中间体结构进行表征; 同时采用圆二色光谱(CD)和噻唑蓝(MTT)法对该聚合物的二级结构和体外毒性进行了考察. 结果表明, 所得星状聚合物的重均分子量(M_w)为4626, 多分散系数(PDI)为1.10, 平均聚合度(DP)为27.1; 在水溶液中星状聚合物的二级结构是无规则线团; 在5 mg/mL浓度下, 细胞存活率可达到94%以上, 没有呈现明显体外细胞毒性, 具有潜在的药用前景.     

Conductometric Studies of Formation the Inclusion Complexes of Phenolic Acids with β-Cyclodextrin and 2-HP-β-Cyclodextrin in Aqueous Solutions

An attempt was made to evaluate the possibility of creating and assessing the stability of inclusion complexes of selected phenolic acids [trans-4-hydroxycinnamic acid (trans-p-coumaric acid), trans-3,4-dihydroxycinnamic acid (trans-caffeic acid), trans-4-hydroxy-3-methoxycinnamic acid, (trans-ferulic acid) and trans-3-phenylacrylic acid (trans-cinnamic acid)] with β-cyclodextrin and 2-HP-β-cyclodextrin in aqueous solutions in a wide temperature range 283.15 K–313.15 K. On the basis of the values of the limiting molar conductivity (Λ_CDNaDod), calculated from the experimental data, the values of the formation constants and the thermodynamic functions of formation (standard enthalpy, entropy, and Gibs standard enthalpy) of the studied complexes were determined. It has been found that the stability of the studied complexes increases with lowering of the molar mass of cyclodextrin and lowering of the temperature.     

Molecular Dynamic Simulation Analysis on the Inclusion Complexation of Plumbagin with β-Cyclodextrin Derivatives in Aqueous Solution

Stable encapsulation of medically active compounds can lead to longer storage life and facilitate the slow-release mechanism. In this work, the dynamic and molecular interactions between plumbagin molecule with β-cyclodextrin (BCD) and its two derivatives, which are dimethyl-β-cyclodextrin (MBCD), and 2-O-monohydroxypropyl-β-cyclodextrin (HPBCD) were investigated. Molecular dynamics simulations (MD) with GLYCAM-06 and AMBER force fields were used to simulate the inclusion complex systems under storage temperature (4 °C) in an aqueous solution. The simulation results suggested that HPBCD is the best encapsulation agent to produce stable host–guest binding with plumbagin. Moreover, the observation of the plumbagin dynamic inside the binding cavity revealed that it tends to orient the methyl group toward the wider rim of HPBCD. Therefore, HPBCD is a decent candidate for the preservation of plumbagin with a promising longer storage life and presents the opportunity to facilitate the slow-release mechanism.     

γ-环糊精对二甲戊灵的包合作用

以γ-环糊精(γ-CD)为主体, 采用饱和水溶液法对客体二甲戊灵进行包合. 采用紫外光谱以等摩尔连续变化法确定包合物的包合比为1∶1; 红外光谱证明二甲戊灵的部分苯环结构可能进入了γ-CD的空腔; 热分析结果证明包合作用提升了二甲戊灵的熔点; 粉末X射线衍射谱图中新衍射峰的出现说明形成了新物相; 扫描电镜则直观展现了包合物的外观. 以上结果均表明形成了γ-CD-二甲戊灵包合物, 其包合平衡常数K=1123.99 L/mol. 包合作用使二甲戊灵的熔点从54 ℃升至75 ℃, 溶解度提高了约11.5倍, 包合物热贮稳定性达标, 为进一步将其加工成其它水基化农药剂型提供了可能.     

β-葡萄糖醛酸苷酶荧光底物试卤灵葡萄糖醛酸苷的高效制备

以猴肝微粒体(CyLM)为酶源, 采用生物制备法实现了荧光底物试卤灵(Resorufin)向试卤灵葡萄糖醛酸苷(Resorufin β-D-glucuronide)的高效转化, 同时借助新型色谱分离材料C18WAX及固相萃取技术实现了Resorufin β-D-glucuronide的高效富集及选择性洗脱, 最终获得纯度大于98%的目标产物. 所得产物结构经LC-MS, ¹H NMR和¹³C NMR等手段进行了表征. 在此基础上, 以该葡萄糖醛酸产物为探针底物建立了β-葡萄糖醛酸苷酶活性检测及抑制剂高通量筛选的方法.     

The Biological Fate of Pharmaceutical Excipient β-Cyclodextrin: Pharmacokinetics,Tissue Distribution,Excretion, and Metabolism of β-Cyclodextrin in Rats

β-cyclodextrin has a unique annular hollow ultrastructure that allows encapsulation of various poorly water-soluble drugs in the resulting cavity, thereby increasing drug stability. As a bioactive molecule, the metabolism of β-cyclodextrin is mainly completed by the flora in the colon, which can interact with API. In this study, understanding the in vivo fate of β-cyclodextrin, a LC-MS/MS method was developed to facilitate simultaneous quantitative analysis of pharmaceutical excipient β-cyclodextrin and API dextromethorphan hydrobromide. The established method had been effectively used to study the pharmacokinetics, tissue distribution, excretion, and metabolism of β-cyclodextrin after oral administration in rats. Results showed that β-cyclodextrin was almost wholly removed from rat plasma within 36 h, and high concentrations of β-cyclodextrin distributed hastily to organs with increased blood flow velocities such as the spleen, liver, and kidney after administration. The excretion of intact β-cyclodextrin to urine and feces was lower than the administration dose. It can be speculated that β-cyclodextrin metabolized to maltodextrin, which was further metabolized, absorbed, and eventually discharged in the form of CO₂ and H₂O. Results proved that β-cyclodextrin, with relative low accumulation in the body, had good safety. The results will assist further study of the design and safety evaluation of adjuvant β-cyclodextrin and promote its clinical development.     

The Enantiomeric Discrimination of 5-Hexyl-2-methyl-3,4-dihydro-2H-pyrrole by Sulfobutyl ether-β-cyclodextrin: A Case Study

1-Pyrrolines are important intermediates of active natural products, such as the 2,5-dialkyl-1-pyrroline derivatives found in fire ant venoms. Here, 5-hexyl-2-methyl-3,4-dihydro-2H-pyrrole was synthesized by the enzymatic transamination/cyclization of 2,5-undecadione, and enantiodifferenciation was successfully achieved by capillary electrophoresis with sulfobutyl ether-β-cyclodextrin as the chiral selector. The rationale of the enantiomeric discrimination was based on the results of a docking simulation that revealed the higher affinity of (S)-5-hexyl-2-methyl-3,4-dihydro-2H-pyrrole for the sulfobutyl ether-β-cyclodextrin.     

Thermal Degradation of Linalool-Chemotype Cinnamomum osmophloeum Leaf Essential Oil and Its Stabilization by Microencapsulation with β-Cyclodextrin

The thermal degradation of linalool-chemotype Cinnamomum osmophloeum leaf essential oil and the stability effect of microencapsulation of leaf essential oil with β-cyclodextrin were studied. After thermal degradation of linalool-chemotype leaf essential oil, degraded compounds including β-myrcene, cis-ocimene and trans-ocimene, were formed through the dehydroxylation of linalool; and ene cyclization also occurs to linalool and its dehydroxylated products to form the compounds such as limonene, terpinolene and α-terpinene. The optimal microencapsulation conditions of leaf essential oil microcapsules were at a leaf essential oil to the β-cyclodextrin ratio of 15:85 and with a solvent ratio (ethanol to water) of 1:5. The maximum yield of leaf essential oil microencapsulated with β-cyclodextrin was 96.5%. According to results from the accelerated dry-heat aging test, β-cyclodextrin was fairly stable at 105 °C, and microencapsulation with β-cyclodextrin can efficiently slow down the emission of linalool-chemotype C. osmophloeum leaf essential oil.     

α-氨基酸及其酯化物侧链对其β-环糊精复合物稳定常数的影响

为了探索α-氨基酸及其酯化物的侧链R基团对其与环糊精非共价复合物结合强度的影响, 将一定摩尔比的β-环糊精(β-CD)分别与L型正缬氨酸(n-Val)、 亮氨酸(Leu)、 苯丙氨酸(Phe)、 天冬氨酸(Asp)、 天冬氨酸-4-苄酯(Asp-4-benzyl ester)和天冬氨酸-4-叔丁酯(Asp-4-t-butyl ester)在室温下混合, 反应平衡后采用电喷雾电离质谱进行竞争反应检测, 并以改进的质谱滴定结合曲线拟合法计算结合常数. 结果表明, 它们均可形成摩尔比为1∶1的非共价复合物. 在2组竞争反应中, 复合物的结合强度顺序分别为[β-CD∶Asp-4-benzyl ester+H]⁺>[β-CD∶Asp-4-t-butyl ester+H]⁺>[β-CD∶Asp+H]⁺以及[β-CD∶Phe+H]⁺>[β-CD∶Leu+H]⁺>[β-CD∶n-Val+H]⁺. 质谱滴定曲线拟合法测得[β-CD∶n-Val+H]⁺, [β-CD∶Asp+H]⁺, [β-CD∶Asp-4-t-butyl ester+H]⁺, [β-CD∶Asp-4-benzyl ester+H]⁺, [β-CD∶Leu+H]⁺和[β-CD∶Phe+H]⁺的稳定常数(lgK_st)分别为1.81, 2.54, 3.14, 3.26, 3.36和3.67, 结合强度依次增强. 竞争反应的定性分析结果与质谱滴定定量法测得结合强度结果的趋势一致. 由于所选用的α-氨基酸及其酯化物客体的羧基端(—COOH)和氨基端(—NH₂)均相同, 且都为亲水基团, 仅有侧链R基团不同, 因此在溶液中客体分子受疏水驱动与β-CD主体靠近并结合时, 侧链R基团的疏水力和极性2个因素起重要作用. 由于客体分子体积小, 其碳端的羧基还可与β-CD大口或小口边缘的羟基形成氢键, 使复合物更加稳定.